Don_Ford t1_j5xrxx2 wrote
Reply to comment by Alex_of_Bree in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
Novavax blows this out of the water.
Viewing a single comment thread. View all comments